Published in Neurology on May 01, 1996
Altered properties of quantal neurotransmitter release at endplates of mice lacking P/Q-type Ca2+ channels. Proc Natl Acad Sci U S A (2003) 1.29
Calcium channels involved in synaptic transmission at the mature and regenerating mouse neuromuscular junction. J Physiol (1996) 1.13
Autoimmunity in amyotrophic lateral sclerosis: past and present. Neurol Res Int (2011) 1.08
Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo. Proc Natl Acad Sci U S A (2008) 1.03
Update on myasthenia gravis. Postgrad Med J (2004) 1.00
Characterization of rhythmic Ca2+ transients in early embryonic chick motoneurons: Ca2+ sources and effects of altered activation of transmitter receptors. J Neurosci (2009) 0.92
Zebrafish calls for reinterpretation for the roles of P/Q calcium channels in neuromuscular transmission. J Neurosci (2013) 0.92
Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons. Proc Natl Acad Sci U S A (1998) 0.90
Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission. J Physiol (2002) 0.88
Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies. J Bioenerg Biomembr (2003) 0.87
Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions. Br J Pharmacol (2002) 0.83
Active zones of mammalian neuromuscular junctions: formation, density, and aging. Ann N Y Acad Sci (2012) 0.83
Axonal function in a family with episodic ataxia type 2 due to a novel mutation. J Neurol (2008) 0.76
In vivo impact of presynaptic calcium channel dysfunction on motor axons in episodic ataxia type 2. Brain (2016) 0.75
Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings. J Physiol (1998) 0.75
Developmental changes in calcium channel types mediating central synaptic transmission. J Neurosci (2000) 1.66
On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates. J Physiol (1980) 1.34
Transmitter release and presynaptic Ca2+ currents blocked by the spider toxin omega-Aga-IVA. Neuroreport (1993) 1.22
Immune reconstitution inflammatory syndrome associated with PML in AIDS: a treatable disorder. Neurology (2006) 1.19
Calcium channels involved in synaptic transmission at the mature and regenerating mouse neuromuscular junction. J Physiol (1996) 1.13
Potassium and calcium conductance in slow muscle fibres of the toad. J Physiol (1976) 1.01
Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction. Br J Pharmacol (1997) 1.01
Calcium channels coupled to neurotransmitter release at neonatal rat neuromuscular junctions. J Physiol (1999) 0.99
Effects of Ca2+ channel blockers on transmitter release and presynaptic currents at the frog neuromuscular junction. J Physiol (1995) 0.98
Coupling of L-type calcium channels to neurotransmitter release at mouse motor nerve terminals. Pflugers Arch (2001) 0.97
Effect of omega-conotoxin GVIA on neurotransmitter release at the mouse neuromuscular junction. Brain Res (1991) 0.96
Properties of postsynaptic channels induced by acetylcholine in different frog muscle fibres. Nature (1981) 0.96
Reduced facilitation and vesicular uptake in crustacean and mammalian neuromuscular junction by T-588, a neuroprotective compound. Proc Natl Acad Sci U S A (1999) 0.94
Properties of junctional and extrajunctional acetylcholine-receptor channels in organ cultured human muscle fibres. J Physiol (1982) 0.93
Evidence for reflex activation of experiential complex partial seizures. Neurology (2001) 0.91
Diffusion of acetylcholine in the synaptic cleft of normal and myasthenia gravis human endplates. Nature (1980) 0.91
Multiple types of calcium channels mediate transmitter release during functional recovery of botulinum toxin type A-poisoned mouse motor nerve terminals. Neuroscience (2000) 0.89
Calcium channels coupled to neurotransmitter release at dually innervated neuromuscular junctions in the newborn rat. Neuroscience (2001) 0.89
Differential expression of alpha 1 and beta subunits of voltage dependent Ca2+ channel at the neuromuscular junction of normal and P/Q Ca2+ channel knockout mouse. Neuroscience (2004) 0.88
Different calcium channels mediate transmitter release evoked by transient or sustained depolarization at mammalian sympathetic ganglia. Neuroscience (1995) 0.87
Single-cell RT-PCR and functional characterization of Ca2+ channels in motoneurons of the rat facial nucleus. J Neurosci (1998) 0.86
Denervation changes in normal and myasthenia gravis human muscle fibres during organ culture. J Physiol (1982) 0.85
Acetylcholine receptors in organ-cultured human muscle fibres. Nature (1979) 0.85
Amyotrophic lateral sclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blocker. Muscle Nerve (2000) 0.83
Reversible Inhibition of Potassium Contractures by optical isomers of verapamil and D 600 on slow muscle fibres of the frog. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.83
Characteristics of membrane channels induced by acetylcholine at frog muscle-tendon junctions. J Physiol (1984) 0.83
L-type calcium channels unmasked by cell-permeant Ca2+ buffer at mouse motor nerve terminals. Pflugers Arch (1999) 0.83
Severe Charcot-Marie-Tooth neuropathy type 1A with 1-base pair deletion and frameshift mutation in the peripheral myelin protein 22 gene. Muscle Nerve (1997) 0.82
P/Q-type calcium channels activate neighboring calcium-dependent potassium channels in mouse motor nerve terminals. Pflugers Arch (1997) 0.82
P/Q-type calcium channel ablation in a mice glycinergic synapse mediated by multiple types of Ca²+ channels alters transmitter release and short term plasticity. Neuroscience (2011) 0.82
Testosterone modulates Ca(v2.2) calcium channels' functional expression at rat levator ani neuromuscular junction. Neuroscience (2005) 0.82
Decreased calcium influx into the neonatal rat motor nerve terminals can recruit additional neuromuscular junctions during the synapse elimination period. Neuroscience (2002) 0.81
Muscarinic autoreceptors related with calcium channels in the strong and weak inputs at polyinnervated developing rat neuromuscular junctions. Neuroscience (2004) 0.81
Development of supersensitivity in denervated slow muscle of the frog. Its dependence on the nerve stump length. Acta Physiol Lat Am (1975) 0.80
Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem Res (1997) 0.79
Nonacceptance of innervation by innervated neonatal rat muscle. Dev Biol (1977) 0.78
Pharmacological characterization of the voltage-dependent Ca2+ channels present in synaptosomes from rat and chicken central nervous system. J Neurochem (1995) 0.78
Potassium channels from normal and denervated mouse skeletal muscle fibers. Muscle Nerve (1993) 0.78
Nifedipine-mediated mobilization of intracellular calcium stores increases spontaneous neurotransmitter release at neonatal rat motor nerve terminals. J Pharmacol Exp Ther (2003) 0.78
Uptake of immunoglobulin G from amyotrophic lateral sclerosis patients by motor nerve terminals in mice. J Neurol Sci (1996) 0.77
A study of the submaxillaris muscle of the frog. J Physiol (1984) 0.77
Induction of action potentials in cultured slow muscle fibres of the frog. J Physiol (1980) 0.77
Ca2+ role on the effect of phorbol esters on the spontaneous quantal release of neurotransmitter at the mouse neuromuscular junction. Brain Res (1990) 0.76
Mammalian neuromuscular transmission blocked by funnel web toxin. Ann N Y Acad Sci (1993) 0.76
Characteristics of synaptic currents in frog muscle fibers of different types. J Neurosci Res (1987) 0.76
Muscle contraction during hyperpolarizing currents in the crab. J Gen Physiol (1974) 0.75
[Hydrosyringomyelia in demyelinating diseases]. Neurologia (2002) 0.75
Ca-dependent slow action potentials in neuromuscular diseases. J Cell Physiol (1990) 0.75
Ca-dependent slow action potentials in human skeletal muscle. J Cell Physiol (1988) 0.75
Electrophysiologic denervation changes of human muscle fibers in motoneuron diseases. Muscle Nerve (1986) 0.75
Induction of action potentials in frog slow muscle fibres paralysed by alpha -bungarotoxin. Proc R Soc Lond B Biol Sci (1981) 0.75
Newly recognized congenital myasthenic syndrome associated with high conductance and fast closure of the acetylcholine receptor channel. Ann Neurol (1993) 0.75
Visualization of satellite cells in living muscle fibres of the frog. Proc R Soc Lond B Biol Sci (1980) 0.75
Electrical properties of normal, denervated and organ-cultured slow fibres of toad cruralis muscles. Pflugers Arch (1989) 0.75
Bilateral and simultaneous ischemic optic neuropathy following hip replacement surgery. Neurologia (2000) 0.75